WATCH: Tucker Hosts No-Holds-Barred Interview With RFK Jr

"The rise of censorship, the rise of suppression of kind of religious freedoms, of property rights, closing a million businesses without just compensation or due process, the abolition of jury trials, which are guaranteed the Sixth and Seventh Amendment for any vaccine company that hurts you, all of these-- and the rise of kind of track-and-trace surveillance state, has been troubling to people, both Democrats and Republicans," Kennedy said.

"People who support vaccines, people who oppose them, are looking at this and wondering what's happened."

Kennedy said that his years of practicing environmental law showcased how government agencies engage in "corporate capture" – wherein they sometimes make money and/or exert control over otherwise private interests like pharmaceutical companies.

"Regulating industries [sometimes] assert control over the agencies that are supposed to regulate them, and essentially turn them into sock puppets," he said. "I've been working on vaccine issues since 2005. And the kind of regulatory capture that you see in that space is really capture-on-steroids, because … the FDA gets 45% of its budget from vaccine companies, from the [pharma] industry," he claimed.

Kennedy compared that idea to a hypothetical situation in which the EPA would be fiscally assisted by fossil fuel companies.

The Kennedy scion also said he has crossed paths with Biden medical adviser Anthony Fauci multiple times over the years, somewhat owing to his late uncle Edward's role as longtime Massachusetts Democratic lawmaker and onetime chairman of the Senate Health & Education Committee.

"Tony Fauci's agency owns half of the Moderna patent, and stands to make billions and billions of dollars on sales of the Moderna vaccine," Kennedy claimed.

Preliminary data were collected from June 2006 through October 2009 on 715,000 patients, and 1.4 million doses (of 45 different vaccines) were given to 376,452 individuals. Of these doses, 35,570 possible reactions (2.6 percent of vaccinations) were identified. This is an average of 890 possible events, an average of 1.3 events per clinician, per month. These data were presented at the 2009 AMIA conference.

In addition, ESP:VAERS investigators participated on a panel to explore the perspective of clinicians, electronic health record (EHR) vendors, the pharmaceutical industry, and the FDA towards systems that use proactive, automated adverse event reporting.

Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA).

Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of "problem" drugs and vaccines that endanger public health. New surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians' usual workflow, takes time, and is duplicative. Proactive, spontaneous, automated adverse event reporting imbedded within EHRs and other information systems has the potential to speed the identification of problems with new drugs and more careful quantification of the risks of older drugs.

Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation.